The screen for cognitive impairment in psychiatry in patients with borderline personality disorder
- PMID: 35146968
- PMCID: PMC9788074
- DOI: 10.1002/pmh.1539
The screen for cognitive impairment in psychiatry in patients with borderline personality disorder
Abstract
Cognitive deficits are common in borderline personality disorder (BPD) and appear to be associated with psychopathology, functioning and outcome. The availability of a cognitive screening instrument could be of use in clinical settings in order to assess neurocognition in BPD patients. The Screen for Cognitive Impairment for Psychiatry (SCIP) proved to be reliable in different psychiatric populations, but it has not yet been validated in personality disorders. The purpose of this study is therefore to evaluate its psychometric properties in a sample of 58 BPD patients. The SCIP was validated against the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the Trail Making Test A and B (TMT A and B). The receiver operator curve analysis displayed an acceptable convergent validity (total score AUC: 0.78, 95% CI: 0.70-0.86; Se: 75%, Sp: 72%). A cut-off total score of 80 identified 81% of patients as cognitively impaired. The exploratory factor analysis displayed a one-factor solution explaining 55.8% of the total variance. The SCIP displayed adequate psychometric properties in BPD and could be integrated in the routine clinical assessment to provide a preliminary evaluation of cognitive features for BPD.
© 2022 The Authors Personality and Mental Health Published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no conflict of interests.
References
-
- Bakkour, N. , Samp, J. , Akhras, K. , El Hammi, E. , Soussi, I. , Zahra, F. , Duru, G. , Kooli, A. , & Toumi, M. (2014). Systematic review of appropriate cognitive assessment instruments used in clinical trials of schizophrenia, major depressive disorder and bipolar disorder. Psychiatry Research, 216(3), 291–302. 10.1016/j.psychres.2014.02.014 - DOI - PubMed
-
- Baldez, D. P. , Biazus, T. B. , Rabelo‐da‐Ponte, F. D. , Nogaro, G. P. , Martins, D. S. , Kunz, M. , & Czepielewski, L. S. (2021). The effect of antipsychotics on the cognitive performance of individuals with psychotic disorders: Network meta‐analyses of randomized controlled trials. Neuroscience and Biobehavioral Reviews, 126, 265–275. 10.1016/j.neubiorev.2021.03.028 - DOI - PubMed
-
- Bazanis, E. , Rogers, R. D. , Dowson, J. H. , Taylor, P. , Meux, C. , Staley, C. , Nevinson‐Andrews, D. , Taylor, C. , Robbins, T. W. , & Sahakian, B. J. (2002). Neurocognitive deficits in decision‐making and planning of patients with DSM‐III‐R borderline personality disorder. Psychological Medicine, 32(8), 1395–1405. 10.1017/S0033291702006657 - DOI - PubMed
-
- Belvederi Murri, M. , Folesani, F. , Costa, S. , Biancosino, B. , Colla, C. , Zerbinati, L. , Caruso, R. , Nanni, M. G. , Purdon, S. E. , & Grassi, L. (2020a). Screening for cognitive impairment in non‐affective psychoses: A comparison between the SCIP and the MoCA. Schizophrenia Research, 218, 188–194. 10.1016/j.schres.2020.01.005 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources